See also this year's filing and all EDGAR filings for this company.
PDF Report 0000315545_2023_Provectus_Biopharmaceuticals_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000315545, Provectus Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,899,182 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 20,941 |
| 3 | remainder_Assets | 117,123 |
| 4 | LiabilitiesCurrent | 8,192,380 |
| 5 | LiabilitiesNoncurrent | 73,376 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,025,142 |
| 9 | ResearchAndDevelopmentExpense | 2,376,143 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 989,042 |
| 12 | remainder_NetIncome | -132,515 |
| 13 | remainder_ComprehensiveNetIncome | -4,571 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,037,246 |
| 1 | Liabilities | 8,265,756 |
| 2 | Expenses | 4,401,285 |
| 3 | Revenues | 989,042 |
| 4 | StockholdersEquity | -6,228,510 |
| 5 | NetIncome | -3,544,758 |
| 6 | ComprehensiveNetIncome | -3,547,044 |
| 7 | BaseVar | 7,915,208 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.32 |
| 9 | EconomicCapitalRatio | 0.583 |
Edgar->Model Mapping
Feature Distribution
Change over Time
